What is the primary purpose of this 8-K filing for WellPoint, Inc.?

The primary purpose of this 8-K filing is to disclose a material definitive agreement, specifically the new employment agreement entered into with the company's President and Chief Executive Officer, Larry C. Glasscock.

What are the key terms of Mr. Glasscock's new employment agreement regarding compensation?

Mr. Glasscock's new employment agreement includes an annual base salary of $1,250,000, an annual incentive bonus opportunity with a target of 125% of his base salary, and annual incentive equity grants. Base salary and target bonus are subject to review for potential increases.

What severance benefits are provided to Mr. Glasscock under this agreement?

In the event of termination by the company without cause or by Mr. Glasscock for 'good reason,' he is entitled to a severance benefit equal to three times the sum of his annual base salary and target annual incentive, paid over three years. Additionally, all outstanding equity awards vest fully, and he receives continued health benefits for three years and an office support stipend.

Are there any restrictions on Mr. Glasscock's activities after employment?

Yes, Mr. Glasscock has agreed to restrictive covenants for 24 months following termination, including not competing with the company, not soliciting employees, and not soliciting clients. He also agrees to preserve company confidences indefinitely and cooperate with the company. Violations can lead to forfeiture of certain benefits.

ELV 8-K: Material Agreements

Summary

Elevance Health, Inc. (then known as WellPoint, Inc.) filed this 8-K on December 30, 2005, to report a material definitive agreement concerning the employment of its President and CEO, Larry C. Glasscock. The filing details a new employment agreement extending Mr. Glasscock's tenure through December 31, 2008, with provisions for automatic extension unless either party provides a year's notice. This agreement outlines his compensation, including a base salary of $1,250,000, an annual incentive bonus target of 125% of base salary, and equity grants. It also specifies benefits such as participation in executive plans, post-retirement medical coverage, and use of corporate aircraft. The agreement also provides for significant severance benefits in the event of termination by the company (without cause) or by Mr. Glasscock for "good reason," including three times his annual base salary plus target bonus, continued benefits for three years, and full vesting of equity awards. It also includes non-compete, non-solicitation, and confidentiality clauses with forfeiture provisions for breaches. This filing is important for investors as it signals a commitment to leadership continuity and outlines the terms governing executive compensation and potential separation, which can impact future financial performance and shareholder value.

Key Highlights

1WellPoint, Inc. (now Elevance Health) entered into a new employment agreement with President and CEO Larry C. Glasscock, extending his term through December 31, 2008.
2The agreement includes provisions for automatic extension of the employment term, creating a minimum one-year remaining term unless notice is given.
3Mr. Glasscock's annual base salary is set at $1,250,000, with a target annual incentive bonus of 125% of base salary.
4The agreement provides for significant severance benefits, including three times the sum of base salary and target incentive, if terminated by the company without cause or by Mr. Glasscock for good reason.
5Equity awards will fully vest upon certain termination events (e.g., termination without cause, good reason, retirement, death, disability).
6The agreement includes post-retirement medical coverage and the use of corporate aircraft for Mr. Glasscock.
7Restrictive covenants include non-compete, non-solicitation, and confidentiality clauses, with specified forfeitures for breaches.

Elevance Health, Inc. 8-K Report, Material Agreement (Dec 30, 2005)

Summary

Key Highlights

Frequently Asked Questions